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Isolated mouse tail skin was UV-irradiated in vitro at 
a dose of 40 mJ/cm2 from both sides to remove the Ia 
immunogenicity. Immediately after irradiation the skin 
was transplanted onto the flank of allogeneic mice. 
When there was a total H-2 difference between donor 
and recipient, the UV-irradiated skin did not show a 
prolonged survival compared to control grafts. In the 
case of an 1-region difference only, i.e. , BlO.AQR grafts 
onto BlO.T (6R) recipients, a significant prolongation 
of the survival time was observed, whereas 50% of the 
UV-treated grafts were not rejected at all. 
In mice, as well in other species like guinea pigs and humans, 
the class I antigens of the major histocompatibility complex 
(MHC), are expressed on all nucleated cells including most 
epiderma l cells. In contrast, t he class II antigens have a more 
restricted tissue distribution and, in the healthy epidermis, they 
are detectable only on t he Langerhans cell [1]. Recently, it was 
found in studies us ing chimeras t hat the Langerhans cell in the 
skin carries t he Ia antigens from the donor, showing that t his 
cell is a nonep idermal bone marrow-derived cell [2] . From 
different transplantation studies it has become clear that such 
!a-bearing passenger leukocytes play an important role in a l-
lograft immunogenicity. Corneal transplants, which are Lan -
gerhans cell deficient, are accepted across class II differences 
but are rejected across a class I difference (3]. Elimination of 
passenger leukocytes from thyroid [ 4] and islet of Langer hans 
[5] a llografts prevents rejection even when there are whole H -
2 differences between donor and recipient . Theoretically, by 
removing the Ia-bearing cells from the skin, t ransplan tation 
across I region a nd, possibly, complete H-2 differences should 
be feasible. UV -irradiation of the stimulator lymphocytes in an 
a llogeneic mixed leukocyte reaction (MLR), will prevent blast 
fo rmation, whereas the class I a ntigens are still detectable on 
UV-treated cells [6] . As t he MLR is seen as the recogni t ion 
p hase of t he t ransplantation reaction , induced by class II dif-
fere nces, a s imilar approach may be used for a skin graft model. 
In vit ro UVB irradiation of Langerhans cells a lso resul ts in a 
reduction of their stimulatory capacit ies with respect to allo-
geneic T lymphocytes [7] . Moreover, in vivo UV-irradiation of 
murine skin induces a t ransient loss of ATPase-positive, !a-
positive cells from the epidermis, but in cont rast with the in 
vitro experiments t hese skin grafts are no Jess immunogenic 
fo r Ia a ntige ns t ha n unirradiated skin (3]. In t he present 
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DAYS AFTER TRANSPLANTATION 
F I G 1. B10.AQR Skin grafts were transplanted to 810.T(6R) recip-
ients. C = untreated controls (n = 12), U = UV-treated skin grafts (n 
= 12). Overall p = 0.001 6. 
experiments, skin grafts were UV -irradiated in vitro before 
t heir imunogenicity was tested in a skin gra ft model. 
MATERIALS AND METHODS 
Sk.in Graft s 
Donor ta il skin (1 X 1 em) was grafted onto the flank of the 
recipients. A plas ter bandage was used to cove r the graft; it was removed 
on day 10 aft er t ransplanta tion. The fate of the grafts was fo llowed 
by daily macroscopic inspection. The gra fts were conside red to be 
rejected when no viable epidermis remained. In all experiments donors 
and recipients were of the same sex. The followi ng congenic inbred 
strains were used: 810.A(2R) , (kkk/db); BlO.T(6R) , (qqqd); and 
BlO.AQR, (qkk/dd). 
Ultraviolet Radiation. 
Ultraviolet radiation was administered with a bank of 6 Sylvania 
UV6 fluorescent tubes (Waldman, Schwennigen, F.R.G.). The spectral 
distribution of the lamps was determined and described previously 
[8] . Tail skin was removed from the donors and kept in a Petri dish 
containing phosphate-buffered saline. Care was taken to assure that. 
the skin was f1attened on the bottom of the dishes. the skin was then 
irradiated on both sides with UVB (40 mJ/cm2) at a dose rate of 0.445 
mJ/cm2/s. Immediately after irradiation the skin was transplanted. 
RESULTS 
When skin grafts were transplanted across a complete H-2 
difference, i.e., BlO.T(6R) grafts onto B10.A(2R) recipients, no 
significant differences were observed between untreated cont rol 
grafts (mean survival t ime 12. 1 ± 2.8 days, n = 6) a nd UV-
treated grafts (mean survi va l ti me 11.0 ± 2.2 days, n = 10). 
However, when t he t ranspla ntation was done across an !-region 
difference only, i.e., B10.AQR grafts onto B10.T(6R) recipients, 
a significant difference in survival was observed between con -
trol and UV -irradiated gra fts (Fig 1). When t he skin was t reated 
with UV radiation, a s ignificant prolongation of the graft 
survi val was found and 50% of t he rec ipients did not reject 
their grafts at. all. 
32 CLAAS ET AL 
DISCUSSION 
T he present results are in contrast with t hose of Streilein et 
al (3], who did not find any influence on skin graft survival 
when the donor mice were irradiated with UV before transplan -
tation. The difference between our and their experiments is the 
in vitro vs the in vivo irradiation. As the !a-positive cells in the 
skin are from bone-marrow origin [2], it may well be possible 
that in the experiment of Streilein and coworkers some !a-
positive cells still migrate from the blood into the epidermis 
before the skin is transp lanted. This possibility can be excluded 
by in vitro UV treatment of the isolated grafts. Another crucial 
difference is that in our test system the skin was irradiated 
from both sides. This may be a very efficient way to remove 
the Ia stimulus from cells in both the dermis and the epidermis. 
Furthermore, tail skin may be a more favorable target for UV 
irradiation as the concentration of Langerhans cells is much 
lower compared to trunk skin (9]. 
In the case of an 1-region difference only, the Ia antigens on 
the surface of the Langer hans ce lls serve both as immunogenic 
molecules and as targets for rejection. Therefore it is difficult 
to distinguish whether the UVB treatment changes the afferent 
limb or the efferent limb of the immune response to these 
antigens. UVB irradiation of stimulator cells in an allogeneic 
MLR prevents blast formation, showing that the induction of 
the immune response is certainly influenced. It cannot be 
excluded that the class II antigens on UV -treated cells are still 
suitable targets for rejection as the class II molecules can still 
be demonstrated on UV-treated cells by a lloantibodies [10]. 
Depletion of epidermal Langerhans cells in the skin by 
repeated tape-stripping can also prolong skin graft survival 
across an l -region difference [11] . Furthermore, we have prelim-
inary data showing that similar results can be obtained by 
treating the skin grafts with anti-Ia serum and complement 
before transplantation. All these data indicate that the Langer-
hans cell plays a central role in the rejection of !a-incompatible 
skin grafts. When skin grafts are transplanted across a total 
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H-2 difference, the Langerhans cell seems to be of mino.r 
importance. 
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